Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
Health & Biotech
Orthocell secures regulatory approval to launch Remplir sales in Singapore
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
Health & Biotech
Orthocell delivers second quarter of record revenue
News
Closing Bell: Arcadium soars 47pc as Rio makes move; retailers beg RBA to cut rates before Christmas
Health & Biotech
Health Check: Long-suffering Mesoblast investors dare to dream
Health & Biotech
ASX health stocks capitalise on growing Southeast Asian market
Health & Biotech
Bio Curious: Nerve repair house plans to break the IPO drought
Health & Biotech
Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada
Stockhead TV
Break it Down: Orthocell smiles on key sales
Stockhead TV
Long Shortz with Orthocell: Changing lives for the better around the world
Health & Biotech
Orthocell ramps up global expansion of market-leading regenerative medicine products
Health & Biotech
Australia’s medical manufacturing sector – a global success story in the making
Health & Biotech
Beyond Resources Part 2: ASX companies driving WA’s medical and life sciences sector
Health & Biotech
Beyond resources: WA aims to be medical and life sciences powerhouse
Health & Biotech
National biotech summit shows off a wealth of healthcare and medical innovation
Health & Biotech
Orthocell to sell Striate+ in Canada after regulatory approval
News
